NCT00755079View on ClinicalTrials.gov

Use of an Oral Beta-2 Agonist in Persons With Spinal Cord Injury

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

August 31, 2012

Study Completion Date

December 31, 2014

Conditions
Spinal Cord Injury
Interventions
DRUG

extended release beta-2 adrenergic agonist

Albuterol extended release belongs to a class of drugs known as bronchodilators. It works in the airways by opening breathing passages and relaxing muscles.

DRUG

placebo

An ambiguous sheathing capsule will be placed over a lactose placebo pill. The placebo will have no effect on pulmonary function.

Trial Locations (1)

10468

VA Medical Center, Bronx, The Bronx

All Listed Sponsors
lead

US Department of Veterans Affairs

FED

NCT00755079 - Use of an Oral Beta-2 Agonist in Persons With Spinal Cord Injury | Biotech Hunter | Biotech Hunter